Carefusion Provides Update on Voluntary Global Recall of Avea® Ventilator

CareFusion, a BD company (NYSE:BDX), provided an update on a global voluntary recall that was initiated on April 21, 2015 to address an issue with certain units of AVEA® ventilators. The recall has been designated as a Class I recall by the U.S. Food and Drug Administration (FDA), which means the Agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death.

Product Images
Click a thumbnail to see full size image (FDA image source)
  • Carefusion Provides Update on Voluntary Global Recall of Avea® Ventilator
 
 
comments powered by Disqus